2020
32 Meconium Disease
Escobar M, Caty M. 32 Meconium Disease. 2020, 517-535. DOI: 10.1016/b978-0-323-54940-0.00032-8.Peer-Reviewed Original ResearchClinical manifestations of cystic fibrosisMeconium plug syndromeNeonatal intensive care unitDistal intestinal obstruction syndromeCF transmembrane regulatorMeconium ileusManifestations of cystic fibrosisEmergent operative explorationCongenital bilateral absenceIntestinal obstruction syndromeBiliary tract diseaseClearance of secretionsLong-term complicationsGastroesophageal reflux diseaseIntensive care unitAssociated with CFPulmonary managementFibrosing colonopathyComplications of MIContrast enemaMeconium diseaseBilateral absenceNewborn periodObstruction syndromeTransmembrane regulator
2002
Towards the pharmacogenomics of cystic fibrosis
Sangiuolo F, DApice M, Bruscia E, Lucidi V, Novelli G. Towards the pharmacogenomics of cystic fibrosis. Pharmacogenomics 2002, 3: 75-87. PMID: 11966405, DOI: 10.1517/14622416.3.1.75.Peer-Reviewed Original ResearchConceptsCystic fibrosisPancreatic insufficiencyChronic obstructive lung diseaseRelated clinical diseasesObstructive lung diseaseElevated sweat chloride concentrationsExocrine pancreatic insufficiencySweat chloride concentrationCongenital bilateral absenceMultiorgan diseaseChronic pancreatitisClinical symptomsLung diseaseDrug therapyClinical diseaseClinical overlapRecessive genetic diseaseTherapeutic questionsBilateral absenceDrug efficacyDiseaseVas deferensTherapy approachesFibrosisSymptoms
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply